BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27795849)

  • 1. Whole-Genome DNA Methylation Analysis of Peripheral Blood Mononuclear Cells in Multiple Sclerosis Patients with Different Disease Courses.
    Kulakova OG; Kabilov MR; Danilova LV; Popova EV; Baturina OA; Tsareva EY; Baulina NM; Kiselev IS; Boyko AN; Favorov AV; Favorova OO; Vlassov VV
    Acta Naturae; 2016; 8(3):103-110. PubMed ID: 27795849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genome-Wide Analysis of DNA Methylation in Cd4+ T Lymphocytes of Patients with Primary Progressive Multiple Sclerosis Indicates Involvement of This Epigenetic Process in the Disease Immunopathogenesis].
    Kiselev IS; Kulakova OG; Danilova LV; Baturina OA; Kabilov MR; Popova EV; Boyko AN; Favorova OO
    Mol Biol (Mosk); 2022; 56(3):468-475. PubMed ID: 35621102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
    Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
    Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparison of DNA methylation profiles of blood mononuclear cells in patients with multiple sclerosis in remission and relapse].
    Kiselev IS; Kulakova OG; Baturina OA; Kabilov MR; Boyko AN; Favorova OO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7. Vyp. 2):60-64. PubMed ID: 37560835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNA Methylation Profile of CD14+ Monocytes Changes in Primary Progressive Multiple Sclerosis].
    Kiselev IS; Kulakova OG; Baturina OA; Kabilov MR; Boyko AN; Favorova OO
    Mol Biol (Mosk); 2023; 57(5):819-826. PubMed ID: 37752647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
    Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
    J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.
    Knapp R; Hardtstock F; Krieger J; Wilke T; Maywald U; Chognot C; Muros-Le Rouzic E; Craveiro L
    Mult Scler Relat Disord; 2022 Dec; 68():104245. PubMed ID: 36306609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis by phenotype in Germany.
    Engelhard J; Oleske DM; Schmitting S; Wells KE; Talapala S; Barbato LM
    Mult Scler Relat Disord; 2022 Jan; 57():103326. PubMed ID: 35158442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of an untargeted metabolomics approach using a 2D GC-GC-MS platform to distinguish relapsing and progressive multiple sclerosis.
    Datta I; Zahoor I; Ata N; Rashid F; Cerghet M; Rattan R; Poisson LM; Giri S
    bioRxiv; 2024 Feb; ():. PubMed ID: 38370675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study.
    Blinkenberg M; Kjellberg J; Ibsen R; Magyari M
    Mult Scler Relat Disord; 2020 Nov; 46():102567. PubMed ID: 33296969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
    Ratzer R; Søndergaard HB; Christensen JR; Börnsen L; Borup R; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Dec; 19(14):1841-8. PubMed ID: 24085340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of IFN-β inducible gene expression in primary-progressive and relapsing-remitting multiple sclerosis.
    Boppana S; Mindur JE; Balashov KE; Dhib-Jalbut S; Ito K
    J Neuroimmunol; 2013 Dec; 265(1-2):68-74. PubMed ID: 24200257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing-Remitting and Primary Progressive Multiple Sclerosis.
    Cao Y; Diao W; Tian F; Zhang F; He L; Long X; Zhou F; Jia Z
    Neuropsychol Rev; 2021 Dec; 31(4):703-720. PubMed ID: 33582965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
    Malhotra S; Fissolo N; Tintoré M; Wing AC; Castilló J; Vidal-Jordana A; Montalban X; Comabella M
    J Neuroinflammation; 2015 Mar; 12():48. PubMed ID: 25879961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of multiple sclerosis phenotypes on burden of disease in Finland.
    Purmonen T; Hakkarainen T; Tervomaa M; Ruutiainen J
    J Med Econ; 2020 Feb; 23(2):156-165. PubMed ID: 31617776
    [No Abstract]   [Full Text] [Related]  

  • 16. Generation of RRMS and PPMS specific iPSCs as a platform for modeling Multiple Sclerosis.
    Mutukula N; Man Z; Takahashi Y; Iniesta Martinez F; Morales M; Carreon-Guarnizo E; Hernandez Clares R; Garcia-Bernal D; Martinez Martinez L; Lajara J; Nuñez Delicado E; Meca Lallana JE; Izpisua Belmonte JC
    Stem Cell Res; 2021 May; 53():102319. PubMed ID: 33894548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of Polish patients with primary progressive multiple sclerosis.
    Brola W; Sobolewski P; Żak M; Flaga S; Fudala M; Siutka D; Kapica K; Chorąży M; Kułakowska A; Perenc A; Bartosik-Psujek H; Psujek M; Głąbiński A; Pawełczyk M; Gacek S; Potemkowski A
    Mult Scler Relat Disord; 2019 Aug; 33():33-38. PubMed ID: 31146082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
    Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inner Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive Multiple Sclerosis.
    Gernert JA; Böhm L; Starck M; Buchka S; Kümpfel T; Kleiter I; Havla J
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of serum inflammatory parameters in progressive forms of multiple sclerosis.
    Nowak-Kiczmer M; Niedziela N; Czuba ZP; Sowa P; Wierzbicki K; Lubczyński M; Adamczyk-Sowa M
    Mult Scler Relat Disord; 2023 Nov; 79():105004. PubMed ID: 37738756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.